Exagen Inc. XGN Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $66.58M+19.7% | $55.64M+5.9% | $52.55M+15.3% | $45.56M-5.7% | ||
| $27.78M+23.3% | $22.53M-2.4% | $23.09M-4.6% | $24.21M+17.6% | ||
| $38.8M+17.2% | $33.11M+12.4% | $29.46M+38.0% | $21.35M-23.0% | ||
| 58.3%-1.2pp | 59.5%+3.5pp | 56.1%+9.2pp | 46.9%-10.5pp | ||
| $6.25M+16.4% | $5.38M+10.5% | $4.87M-50.7% | $9.88M+36.5% | ||
| $46.62M+12.7% | $41.37M-12.8% | $47.43M-8.8% | $52.02M+16.8% | ||
| $52.87M+13.1% | $46.75M-17.2% | $56.47M-38.4% | $91.61M+26.6% | ||
| -$14.07M-3.2% | -$13.64M+40.3% | -$22.84M+50.4% | -$46.05M-91.3% | ||
| -21.1%+3.4pp | -24.5%+19.0pp | -43.5%+57.6pp | -101.1%-51.2pp | ||
| $4.32M+93.3% | $2.23M-4.3% | $2.34M-4.6% | $2.45M-6.7% | ||
| —— | —— | —— | —— | ||
| $51K+325% | $12K-63.6% | $33K+112% | -$282K-261% | ||
| -$19.95M-32.0% | -$15.12M+36.2% | -$23.69M+50.0% | -$47.39M-76.5% | ||
| -30%-2.8pp | -27.2%+17.9pp | -45.1%+58.9pp | -104%-48.4pp | ||
| -$0.92-10.8% | -$0.83+38.1% | -$1.34+51.4% | -$2.76-63.3% | ||
| -$14.07M-3.2% | -$13.64M+40.3% | -$22.84M+50.4% | -$46.05M-91.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Exagen Inc.'s revenue?
- Exagen Inc. (XGN) generated $68.4M in revenue over the trailing twelve months, up 20.5% year over year.
- Is Exagen Inc. profitable?
- Exagen Inc. is not currently profitable: it reported a net loss of $20.2M over the trailing twelve months, a -29.5% net margin.
- What are Exagen Inc.'s profit margins?
- Gross margin is 58.3% and operating margin is -20.6%, with a -29.5% net margin.
- What is Exagen Inc.'s earnings per share?
- Exagen Inc.'s diluted EPS over the trailing twelve months is $-0.89.
- Where does Exagen Inc.'s income statement data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
